Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Northeast Tiger Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Northeast Tiger Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Northwest Biotherapeutics Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Northwest Biotherapeutics Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Nova BioGenetics Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Nova BioGenetics Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

NovaBay Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

NovaBay Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novadel Pharma Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novadel Pharma Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

NovaDx Ventures Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

NovaDx Ventures Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novagali Pharma S.A. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novagali Pharma S.A. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novartis India Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novartis India Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novartis AG - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novartis AG - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novavax, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novavax, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novelos Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novelos Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

November AG - Business Profile with Financial and SWOT Analysis

US$ 200.00

November AG - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novo Nordisk A/S - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novo Nordisk A/S - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Novogen Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Novogen Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

NPS Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

NPS Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

NuPathe, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

NuPathe, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

NuRx Pharmaceuticals, Inc - Business Profile with Financial and SWOT Analysis

US$ 200.00

NuRx Pharmaceuticals, Inc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Nusep Holdings Ltd - Business Profile with Financial and SWOT Analysis

US$ 200.00

Nusep Holdings Ltd - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Nutra Pharma Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Nutra Pharma Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Nutraplus Products (India) Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Nutraplus Products (India) Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Nuvo Research Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Nuvo Research Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Nymox Pharmaceutical Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Nymox Pharmaceutical Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Oasmia Pharmaceutical AB - Business Profile with Financial and SWOT Analysis

US$ 200.00

Oasmia Pharmaceutical AB - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Obagi Medical Products, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Obagi Medical Products, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

OBJ Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

OBJ Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Ocean Bright Co. Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Ocean Bright Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

OctoPlus N.V. - Business Profile with Financial and SWOT Analysis

US$ 200.00

OctoPlus N.V. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Oculus Innovative Sciences, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Oculus Innovative Sciences, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Ohr Pharmaceutical, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Ohr Pharmaceutical, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

OJSC Pharmstandard - Business Profile with Financial and SWOT Analysis

US$ 200.00

OJSC Pharmstandard - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Olfactory Biosciences Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Olfactory Biosciences Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Omeros Corp. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Omeros Corp. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Omni Bio Pharmaceutical, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Omni Bio Pharmaceutical, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Omnimmune Holdings, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Omnimmune Holdings, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

OncoGenex Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

OncoGenex Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Oncologix Tech, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Oncologix Tech, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Oncolytics Biotech Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Oncolytics Biotech Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

OncoTherapy Science Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

OncoTherapy Science Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Oncothyreon Inc - Business Profile with Financial and SWOT Analysis

US$ 200.00

Oncothyreon Inc - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

OncoVista Innovative Therapies, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

OncoVista Innovative Therapies, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Ondine Biomedical Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Ondine Biomedical Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

One World Nutrition Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

One World Nutrition Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Oneness Biotech Co., Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Oneness Biotech Co., Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Ono Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Ono Pharmaceutical Co. Ltd. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Onyx Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Onyx Pharmaceuticals Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Opexa Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Opexa Therapeutics, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Opko Health, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Opko Health, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Optigenex Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Optigenex Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Optimer Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Optimer Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Oragenics Inc. - Business Profile with Financial and SWOT Analysis

US$ 200.00

Oragenics Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.

November 2026 30 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1